Partial Loss-of-Function Mutations in Insulin-Degrading Enzyme that Induce Diabetes also Impair Degradation of Amyloid β-Protein

作者: Wesley Farris , Stefan Mansourian , Malcolm A Leissring , Elizabeth A Eckman , Lars Bertram

DOI: 10.1016/S0002-9440(10)63229-4

关键词: InsulysinCandidate geneBiologyInternal medicineHyperinsulinemiaEndocrinologyAmyloidInsulin-degrading enzymeInsulinMutationAlzheimer's disease

摘要: The causes of cerebral accumulation amyloid β-protein (Aβ) in most cases Alzheimer's disease (AD) remain unknown. We recently found that homozygous deletion the insulin-degrading enzyme (IDE) gene mice results an early and marked elevation Aβ. Both genetic linkage allelic association IDE region chromosome 10 have been reported families with late-onset AD. For to a valid candidate for AD on functional grounds, it must be shown partial loss function can still alter Aβ degradation, but without causing early, severe brain Here, we show naturally occurring missense mutations well-characterized rat model type 2 diabetes mellitus (DM2) result decreased catalytic efficiency significant ∼15 30% deficit degradation both insulin Endogenously secreted 40 42 are significantly elevated primary neuronal cultures from animals mutations, there is no increase steady-state levels rodent up age 14 months. conclude occurring, loss-of-function sufficient cause DM2 also impair regulation levels, apparently compensate during life span rat. Our findings relevance emerging evidence suggesting may AD-risk gene, epidemiological relationships among hyperinsulinemia, DM2,

参考文章(65)
Nobuhisa Iwata, Satoshi Tsubuki, Emi Hama, Yoshie Takaki, Keiro Shirotani, Takaomi C. Saido, Reply to: 'Clearance of amyloid β-peptide from brain: transport or metabolism?' Nature Medicine. ,vol. 6, pp. 718- 719 ,(2000) , 10.1038/77399
Atish Mukherjee, Eun-suk Song, Muthoni Kihiko-Ehmann, Jack P. Goodman, Jan St. Pyrek, Steven Estus, Louis B. Hersh, Insulysin Hydrolyzes Amyloid β Peptides to Products That Are Neither Neurotoxic Nor Deposit on Amyloid Plaques The Journal of Neuroscience. ,vol. 20, pp. 8745- 8749 ,(2000) , 10.1523/JNEUROSCI.20-23-08745.2000
S.L. Squazzo, E.H. Koo, Evidence that production and release of amyloid beta-protein involves the endocytic pathway. Journal of Biological Chemistry. ,vol. 269, pp. 17386- 17389 ,(1994) , 10.1016/S0021-9258(17)32449-3
Jianguo Hu, Akira Igarashi, Makiko Kamata, Hachiro Nakagawa, Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity Journal of Biological Chemistry. ,vol. 276, pp. 47863- 47868 ,(2001) , 10.1074/JBC.M104068200
K. Johnson-Wood, M. Lee, R. Motter, K. Hu, G. Gordon, R. Barbour, K. Khan, M. Gordon, H. Tan, D. Games, I. Lieberburg, D. Schenk, P. Seubert, L. McConlogue, Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease Proceedings of the National Academy of Sciences of the United States of America. ,vol. 94, pp. 1550- 1555 ,(1997) , 10.1073/PNAS.94.4.1550
H. F. Dovey, V. John, J. P. Anderson, L. Z. Chen, P. De Saint Andrieu, L. Y. Fang, S. B. Freedman, B. Folmer, E. Goldbach, E. J. Holsztynska, K. L. Hu, K. L. Johnson-Wood, S. L. Kennedy, D. Kholodenko, J. E. Knops, L. H. Latimer, M. Lee, Z. Liao, I. M. Lieberburg, R. N. Motter, L. C. Mutter, J. Nietz, K. P. Quinn, K. L. Sacchi, P. A. Seubert, G. M. Shopp, E. D. Thorsett, J. S. Tung, J. Wu, S. Yang, C. T. Yin, D. B. Schenk, P. C. May, L. D. Altstiel, M. H. Bender, L. N. Boggs, T. C. Britton, J. C. Clemens, D. L. Czilli, D. K. Dieckman-McGinty, J. J. Droste, K. S. Fuson, B. D. Gitter, P. A. Hyslop, E. M. Johnstone, W-Y. Li, S. P. Little, T. E. Mabry, F. D. Miller, B. Ni, J. S. Nissen, W. J. Porter, B. D. Potts, J. K. Reel, D. Stephenson, Y. Su, L. A. Shipley, C. A. Whitesitt, T. Yin, J. E. Audia, Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain Journal of Neurochemistry. ,vol. 76, pp. 173- 181 ,(2009) , 10.1046/J.1471-4159.2001.00012.X
Igor V Kurochkin, Insulin-degrading enzyme: embarking on amyloid destruction Trends in Biochemical Sciences. ,vol. 26, pp. 421- 425 ,(2001) , 10.1016/S0968-0004(01)01876-X
Rudolph E. Tanzi, Lars Bertram, New Frontiers in Alzheimer's Disease Genetics Neuron. ,vol. 32, pp. 181- 184 ,(2001) , 10.1016/S0896-6273(01)00476-7